QA: Skye Bioscience Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2018_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516551, Skye Bioscience Inc

  xvar xval
0 AssetsCurrent 555,811
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,407
3 remainder_Assets 0
4 LiabilitiesCurrent 805,974
5 LiabilitiesNoncurrent 551,322
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,557,587
9 ResearchAndDevelopmentExpense 353,552
10 remainder_Expenses -675,614
11 remainder_Revenues 0
12 remainder_NetIncome 135,326
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 557,218
1 Liabilities 1,357,296
2 Expenses 3,235,525
3 Revenues 0
4 StockholdersEquity -800,078
5 NetIncome -3,100,199
6 ComprehensiveNetIncome -3,100,199
7 BaseVar 2,642,682
8 EconomicCapitalRatiobeforeLimitedLiability -5.06
9 EconomicCapitalRatio 0.182

Edgar->Model Mapping

Feature Distribution

Change over Time